Meet US @ OCT Midwest 2016

OCT Midwest 2016 - Outsourcing in Clinical Trials & CTS banner
 
19-20 July 2016     //     Chicago, IL  
 
Spaulding Clinical Research, LLC invites you to meet us at OCT Midwest 2016 and learn how our paperless, 200-Bed Phase I Clinic and innovative ECG Core Laboratory technology can accelerate your drug's development.
 
Make sure to ask one of our experts about:
 
1)  Our company's 2015 performance Metrics
2)  How we can reduce site burden and the cost of your study with our latest Cardiac Safety Solution.  Here's a teaser:  View Press Release >>
 
If you can't make the event, make sure to check out some of our latest content:
 
 
If you are attending OCT Midwest 2016 and would like to schedule a meeting, please This email address is being protected from spambots. You need JavaScript enabled to view it. or call us at 1-262-334-6020.
 

Spaulding to Disrupt Cardiac Safety Industry with Latest Innovation at DIA 2016

Press Release:

Spaulding Electrocardiograph 2100iQ with Tablet

Spaulding Clinical Research, LLC announced that the Electrocardiograph 2100iQ™ is to be exhibited at the Drug Information Association's (DIA) 2016 conference.

The Spaulding 12-Lead ECG product line was originally launched in 2011 and is now in over 35 countries.

The Electrocardiograph 2100iQ™ has been optimized to visualize collected real-time digital ECG data via Bluetooth™ using iOS™ 7+, Android™ 4.2+ and Windows™ 7+ devices.

It's small, lightweight, and has single button operation for ease of use.  Stores up to 5 minutes of ECG data which can be automatically uploaded wirelessly to the Spaulding webECG™ managment cloud.

 

Shane Braninburg Joins Cardiac Safety Solutions Team

Press Release:

Shane Braninburg photo

June 07, 2016 Spaulding Clinical Research, LLC announced the addition of Shane Braninburg as Senior Director of Core Lab Services.

He brings more than 15 years of global business expertise, including extensive operational experience in Cardiac Safety Services.

Mr. Braninburg is responsible for supporting the rapid growth of Spaulding's ECG Core Lab, including the launch of the Spaulding Electrocardiograph 2100iQ™.

 

Read Full Press Release >>